Cargando…

The effect of breast MRI on disease-free and overall survival in breast cancer patients: a retrospective population-based study

PURPOSE: To evaluate the effect of breast MRI on overall survival (OS) and disease-free survival (DFS) of patients with invasive breast cancer in the Netherlands. METHODS: We selected all women from the Netherlands Cancer Registry diagnosed with invasive breast cancer (a) between 2011 and 2013 for t...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Nijnatten, T. J. A., van Tiel, L. P. T., Voogd, A. C., Groothuis-Oudshoorn, C. G. M., Siesling, S., Lobbes, M. B. I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2020
Materias:	Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7655574/ https://www.ncbi.nlm.nih.gov/pubmed/32930928 http://dx.doi.org/10.1007/s10549-020-05906-w

Ejemplares similares

Omitting re-excision for focally positive margins after breast-conserving surgery does not impair disease-free and overall survival
por: Vos, Elvira L., et al.
Publicado: (2017)

Breast MRI increases the number of mastectomies for ductal cancers, but decreases them for lobular cancers
por: Lobbes, Marc B.I., et al.
Publicado: (2017)

Pathologic complete response and overall survival in breast cancer subtypes in stage III inflammatory breast cancer
por: van Uden, Dominique J. P., et al.
Publicado: (2019)

Comparing quality of breast cancer care in the Netherlands and Norway by federated propensity score analytics
por: Hamersma, Dave T., et al.
Publicado: (2023)

Does the TNM classification of solitary internal mammary lymph node metastases in breast cancer still apply?
por: Habraken, V., et al.
Publicado: (2016)

Improved risk estimation of locoregional recurrence, secondary contralateral tumors and distant metastases in early breast cancer: the INFLUENCE 2.0 model
por: Völkel, Vinzenz, et al.
Publicado: (2021)

Conditional local recurrence risk: the effect of event-free years in different subtypes of breast cancer
por: Moossdorff, M., et al.
Publicado: (2021)

Increased risks of third primary cancers of non-breast origin among women with bilateral breast cancer
por: Kwast, A B G, et al.
Publicado: (2012)

Prognosis of residual axillary disease after neoadjuvant chemotherapy in clinically node-positive breast cancer patients: isolated tumor cells and micrometastases carry a better prognosis than macrometastases
por: van Nijnatten, T. J. A., et al.
Publicado: (2017)

Contralateral breast cancer risk in relation to tumor morphology and age—in which patients is preoperative MRI justified?
por: de Glas, N. A., et al.
Publicado: (2015)

Comprehensive trends in incidence, treatment, survival and mortality of first primary invasive breast cancer stratified by age, stage and receptor subtype in the Netherlands between 1989 and 2017
por: van der Meer, Daniël J., et al.
Publicado: (2020)

Delay in initiation of adjuvant trastuzumab therapy leads to decreased overall survival and relapse-free survival in patients with HER2-positive non-metastatic breast cancer
por: Gallagher, Christopher M., et al.
Publicado: (2016)

The influence of timing of radiation therapy following breast-conserving surgery on 10-year disease-free survival
por: van Maaren, Marissa C, et al.
Publicado: (2017)

Changes in breast cancer treatment during the COVID-19 pandemic: a Dutch population-based study
por: Eijkelboom, Anouk H., et al.
Publicado: (2022)

Diagnostic performance of standard breast MRI compared to dedicated axillary MRI for assessment of node-negative and node-positive breast cancer
por: Samiei, Sanaz, et al.
Publicado: (2020)

Trends in breast biopsies for abnormalities detected at screening mammography: a population-based study in the Netherlands
por: van Breest Smallenburg, V, et al.
Publicado: (2013)

Improved survival of older patients with advanced breast cancer due to an increase in systemic treatments: a population-based study
por: de Glas, Nienke, et al.
Publicado: (2019)

The association of socioeconomic status on treatment strategy in patients with stage I and II breast cancer in the Netherlands
por: Filipe, M. D., et al.
Publicado: (2021)

Racial inequities in second-line treatment and overall survival among patients with metastatic breast cancer
por: Whitaker, Kristen D., et al.
Publicado: (2022)

Overall survival analysis in patients with metastatic breast cancer and liver or lung metastases treated with eribulin, gemcitabine, or capecitabine
por: Kazmi, Shayma, et al.
Publicado: (2020)

The increasing importance of histologic grading in tailoring adjuvant systemic therapy in 30,843 breast cancer patients
por: van Dooijeweert, C., et al.
Publicado: (2021)

Estrogen and progesterone receptor expression levels do not differ between lobular and ductal carcinoma in patients with hormone receptor-positive tumors
por: Truin, Wilfred, et al.
Publicado: (2017)

Concurrent versus sequential use of trastuzumab and chemotherapy in early HER2+ breast cancer
por: Dackus, Gwen M. H. E., et al.
Publicado: (2020)

Metastatic behavior and overall survival according to breast cancer subtypes in stage IV inflammatory breast cancer
por: van Uden, D. J. P., et al.
Publicado: (2019)

Survival and contralateral breast cancer in CHEK2 1100delC breast cancer patients: impact of adjuvant chemotherapy
por: Kriege, M, et al.
Publicado: (2014)

Effectiveness of radiotherapy after breast-conserving surgery in older patients with T1-2N0 breast cancer
por: de Boer, Anna Z., et al.
Publicado: (2019)

Patterns and predictors of first and subsequent recurrence in women with early breast cancer
por: Geurts, Y. M., et al.
Publicado: (2017)

Axillary lymph node characteristics in breast cancer patients versus post-COVID-19 vaccination: Overview of current evidence per imaging modality
por: van Nijnatten, T.J.A., et al.
Publicado: (2022)

Use of the metastatic breast cancer progression (MBC-P) questionnaire to assess the value of progression-free survival for women with metastatic breast cancer
por: Hurvitz, Sara A., et al.
Publicado: (2013)

Personalisation of breast cancer follow-up: a time-dependent prognostic nomogram for the estimation of annual risk of locoregional recurrence in early breast cancer patients
por: Witteveen, Annemieke, et al.
Publicado: (2015)

The impact of health symptoms on health-related quality of life in early-stage breast cancer survivors
por: de Ligt, K. M., et al.
Publicado: (2019)

Specialisation and breast cancer survival in the screening era
por: Kingsmore, D, et al.
Publicado: (2003)

MRI-based radiomics in breast cancer: feature robustness with respect to inter-observer segmentation variability
por: Granzier, R. W. Y., et al.
Publicado: (2020)

Aspirin use and survival after the diagnosis of breast cancer: a population-based cohort study
por: Fraser, D M, et al.
Publicado: (2014)

Routine and interval detection of locoregional breast cancer recurrences and risk of subsequent distant metastasis
por: Eijkelboom, Anouk H., et al.
Publicado: (2022)

Diagnostic performance of axillary ultrasound and standard breast MRI for differentiation between limited and advanced axillary nodal disease in clinically node-positive breast cancer patients
por: Samiei, S., et al.
Publicado: (2019)

Survival of BRCA1/BRCA2-associated pT1 breast cancer patients, a cohort study
por: van Barele, Mark, et al.
Publicado: (2022)

Population‐based study of the effect of preoperative breast MRI on the surgical management of ductal carcinoma in situ
por: Keymeulen, K. B. I. M., et al.
Publicado: (2019)

Treatment and overall survival in renal cell carcinoma: a Swedish population-based study (2000–2008)
por: Wahlgren, T, et al.
Publicado: (2013)

Population-based estimates of overtreatment with adjuvant systemic therapy in early breast cancer patients with data from the Netherlands and the USA
por: Ragusi, M. A. A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o0l862u3mqqk73lhivf7hte6hq